SIGNATURE ESTATE & INVESTMENT ADVISORS LLC
Position in ABBV — AbbVie Inc.
CIK 1079935
LOS ANGELES, CA
Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,336,711
+$141,821 QoQ
Shares Held
5,312
-3.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2,283
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SIGNATURE ESTATE & INVESTMENT ADVISORS LLC holds $78,743,107 across 9 Drug Manufacturers - General names. ABBV ranks #4 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
57,559 | $69,037,996 | |
| 2 | JNJ |
Johnson & Johnson
|
8,972 | $2,278,618 | |
| 3 | AMGN |
Amgen Inc
|
6,232 | $2,256,731 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
5,312 | $1,336,711 | |
| 5 | AZN |
Astrazeneca PLC
|
6,802 | $1,289,794 | |
| 6 | PFE |
Pfizer Inc
|
38,803 | $934,375 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,229 | $928,926 | |
| 8 | NVO |
Novo Nordisk A S
|
8,810 | $422,350 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,336,711 | 5,312 | Shares | Defined | 2026-07-14 | |
| 2026-03-31 | $1,194,890 | 5,494 | Shares | Defined | 2026-04-15 | |
| 2025-12-31 | $1,234,073 | 5,401 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,300,096 | 5,615 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $1,089,959 | 5,872 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $1,368,164 | 6,530 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $1,104,227 | 6,214 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,196,333 | 6,058 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,032,206 | 6,018 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $316,671 | 1,739 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $246,246 | 1,589 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $255,339 | 1,713 | Shares | Defined | 2023-10-26 | |
| 2023-06-30 | $233,082 | 1,730 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $279,852 | 1,756 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $302,533 | 1,872 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $309,756 | 2,308 | Shares | Defined | 2022-10-20 | |
| 2022-06-30 | $368,809 | 2,408 | Shares | Defined | 2022-07-13 | |
| 2022-03-31 | $410,624 | 2,533 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $300,858 | 2,222 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $246,590 | 2,286 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $295,342 | 2,622 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $261,783 | 2,419 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $232,407 | 2,169 | Shares | Sole | 2021-01-13 | |
| No filing history on record for this holder in this stock. | ||||||